Evidence map›Paper›PMID 33256078›Full record

ArticleCells2020

Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination.

Hana Langerová, Barbora Lubyová, Aleš Zábranský, Martin Hubálek, Kristýna Glendová, Ludovic Aillot, Jan Hodek, Dmytro Strunin, Václav Janovec, Ivan Hirsch and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. σCommunications biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hana LangerováInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Barbora LubyováInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Aleš ZábranskýInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Martin HubálekInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.ORCID 0000-0003-0247-7956
Kristýna GlendováInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Ludovic AillotInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.ORCID 0000-0001-8277-3901
Jan HodekInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Dmytro StruninInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Václav JanovecInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.
Ivan HirschInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.ORCID 0000-0003-1701-1438
Jan WeberInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, IOCB Gilead Research Center, 16000 Prague, Czech Republic.ORCID 0000-0002-2799-7352
Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry · CZCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) core protein (HBc) plays many roles in the HBV life cycle, such as regulation of transcription, RNA encapsidation, reverse transcription, and viral release. To accomplish these functions, HBc interacts with many host proteins and undergoes different post-translational modifications (PTMs). One of the most common PTMs is ubiquitination, which was shown to change the function, stability, and intracellular localization of different viral proteins, but the role of HBc ubiquitination in the HBV life cycle remains unknown. Here, we found that HBc protein is post-translationally modified through K29-linked ubiquitination. We performed a series of co-immunoprecipitation experiments with wild-type HBc, lysine to arginine HBc mutants and wild-type ubiquitin, single lysine to arginine ubiquitin mutants, or single ubiquitin-accepting lysine constructs. We observed that HBc protein could be modified by ubiquitination in transfected as well as infected hepatoma cells. In addition, ubiquitination predominantly occurred on HBc lysine 7 and the preferred ubiquitin chain linkage was through ubiquitin-K29. Mass spectrometry (MS) analyses detected ubiquitin protein ligase E3 component N-recognin 5 (UBR5) as a potential E3 ubiquitin ligase involved in K29-linked ubiquitination. These findings emphasize that ubiquitination of HBc may play an important role in HBV life cycle.

Indexed as

ArginineCarcinoma, HepatocellularCell LineCell Line, TumorHEK293 CellsHepatitis BHepatitis B virusHep G2 CellsHumansLysineProtein Processing, Post-TranslationalUbiquitinUbiquitinationUbiquitin-Protein LigasesViral ProteinsArginineLysineUbiquitinUbiquitin-Protein LigasesViral ProteinsE3 ubiquitin-protein ligaseHBchepatitis B viruspost-translational modificationsubiquitinubiquitination

Identifiers

PMID33256078
PMCPMC7760836
OpenAlexW3109297638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.